Skip to main content

Advertisement

SpringerLink
Log in

DNA aptamer-based detection of prostate cancer

  • Review
  • Published:
Chemical Papers Aims and scope Submit manuscript

Abstract

The use of aptamers in biosensing has attracted considerable attention as an alternative to antibodies because of their unique properties such as long-term stability, cost-effectiveness and adjustability to various applications. Among cancers, the early diagnosis of prostate cancer (PCa) is one of the greatest concerns for ageing men worldwide. One of the most commonly used biomarkers for PCa is prostate-specific antigen (PSA), which can be found in elevated levels in patients with cancer. This review presents the gradual transition of research from antibody-based to aptamer-based biosensors, specifically for PSA. A brief description on aptamer-based biosensing for other PCa biomarkers is also presented. Special attention is given to electrochemical methods as analytical techniques for the development of simple, sensitive and cost-effective biosensors. The review also focuses on the different surface chemistries exploited for fabrication and their applications in clinical samples. The use of aptamers represents a promising tool for the development of point-of-care biosensors for the early detection of prostate cancer. In view of the unmatched upper hand of aptamers, future prospects are also discussed, not only in the point-of-care format but also in other novel applications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Acevedo, B., Perera, Y., Ruiz, M., Rojas, G., Benítez, J., Ayala, M., & Gavilondo, J. (2002). Development and validation of a quantitative ELISA for the measurement of PSA concentration. Clinica Chimica Acta, 317, 55–63. DOI: 10.1016/s0009-8981(01)00749-5.

    Article  CAS  Google Scholar 

  • Albrecht, S., Brandl, H., Steinke, M., & Freidt, T. (1994). Chemiluminescent enzyme immunoassay of prostate-specific antigen based on indoxyl phosphate substrate. Clinical Chemistry, 40, 1970–1971.

    CAS  Google Scholar 

  • Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., Weissfeld, J. L., Yokochi, L. A., O’Brien, B., Clapp, J. D., Rathmell, J. M., Riley, T. L., Hayes, R. B., Kramer, B. S., Izmirlian, G., Miller, A. B., Pinsky, P. F., Prorok, P. C., Gohagan, J. K., & Berg, C. D. (2009). Mortality results from a randomized prostate-cancer screening trial. New England Journal of Medicine, 360, 1310–1319. DOI: 10.1056/nejmoa0810696.

    Article  CAS  Google Scholar 

  • Arya, S. K., & Bhansali, S. (2012). Anti-prostate specific antigen (anti-PSA) modified interdigitated microelectrode-based impedimetric biosensor for PSA detection. Biosensors Journal, 1, H110601. DOI: 10.4303/bj/h110601.

    Article  Google Scholar 

  • Aus, G., Ahlgren, G., Bergdahl, S., & Hugosson, J. (1996). Infection after transrectal core biopsies of the prostate. British Journal of Urology, 77, 851–855. DOI: 10.1046/J.1464-410x.1996.01014.x.

    Article  CAS  Google Scholar 

  • Balducci, L., Pow-Sang, J., Friedland, J., & Diaz, J. I. (1997). Prostate cancer. Clinics in Geriatric Medicine, 13, 283–306.

    CAS  Google Scholar 

  • Balk, S. P., Ko, Y. J., & Bubley, G. J. (2003). Biology of prostate-specific antigen. Journal of Clinical Oncology, 21, 383–391. DOI: 10.1200/jco.2003.02.083.

    Article  CAS  Google Scholar 

  • Basler, J. W., & Thompson, I. M. (1998). Lest we abandon digital rectal examination as a screening test for prostate cancer. Journal of the National Cancer Institute, 90, 1761–1763. DOI: 10.1093/jnci/90.23.1761.

    Article  CAS  Google Scholar 

  • Bertok, T., Klukova, L., Sediva, A., Kasák, P., Semak, V., Micusik, M., Omastova, M., Chovanová, L., Vlček, M., Imrich, R., Vikartovska, A., & Tkac, J. (2013). Ultrasensitive impedimetric lectin biosensors with efficient antifouling properties applied in glycoprofiling of human serum samples. Analytical Chemistry, 85, 7324–7332. DOI: 10.1021/ac401281t.

    Article  CAS  Google Scholar 

  • Besselink, G. A. J., Kooyman, R.P.H., van Os, P. J. H. J., Engbers, G. H. M., & Schasfoort, R. B. M. (2004). Signal amplification on planar and gel-type sensor surfaces in surface plasmon resonance-based detection of prostate-specific antigen. Analytical Biochemistry, 333, 165–173. DOI: 10.1016/j.ab.2004.05.009.

    Article  CAS  Google Scholar 

  • Bostwick, D. G. (1989). The pathology of early prostate cancer. CA: A Cancer Journal for Clinicians, 39, 376–393. DOI: 10.3322/canjclin.39.6.376.

    CAS  Google Scholar 

  • Campuzano, S., Pedrero, M., Montemayor, C., Fatás, E., & Pingarrón, J. M. (2006). Characterization of alkanethiol-self-assembled monolayers-modified gold electrodes by electrochemical impedance spectroscopy. Journal of Electroanalytical Chemistry, 586, 112–121. DOI: 10.1016/j.jelechem.2005.09.007.

    Article  CAS  Google Scholar 

  • Cao, C., & Sim, S. J. (2007). Double-enhancement strategy: a practical approach to a femto-molar level detection of prostate specific antigen-α1-antichymotrypsin (PSA/ACT complex) for SPR immunosensing. Journal of Microbiology and Biotechnology, 17, 1031–1035.

    CAS  Google Scholar 

  • Carter, H.B., Pearson, J.D., Metter, E.J., Brant, L.J., Chan, D. W., Andres, R., Fozard, J. L., & Walsh, P. C. (1992). Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA: The Journal of the American Medical Association, 267, 2215–2220. DOI: 10.1001/jama.267.16.2215.

    Article  CAS  Google Scholar 

  • Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D.E., Yuan, J.J.J., Petros, J.A., & Andriole, G. L. (1991). Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New England Journal of Medicine, 324, 1156–1161. DOI: 10.1056/nejm199104253241702.

    Article  CAS  Google Scholar 

  • Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., Lange, P. H., Subong, E. N. P., Parson, R. E., Gasior, G. H., Loveland, K. G., & Southwick, P. C. (1998). Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial. Journal of the American Medical Association, 279, 1542–1547. DOI: 10.1001/jama.279.19.1542.

    Article  CAS  Google Scholar 

  • Chen, Z. G., Lei, Y. L., Chen, X., Wang, Z., & Liu, J. B. (2012). An aptamer based resonance light scattering assay of prostate specific antigen. Biosensors and Bioelectronics, 36, 35–40. DOI: 10.1016/j.bios.2012.03.041.

    Article  CAS  Google Scholar 

  • Chikkaveeraiah, B. V., Mani, V., Patel, V., Gutkind, J. S., & Rusling, J. F. (2011). Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum. Biosensors and Bioelectronics, 26, 4477–4483. DOI: 10.1016/j.bios.2011.05.005.

    Article  CAS  Google Scholar 

  • Chiriacò, M. S., Primiceri, E., Montanaro, A., de Feo, F., Leone, L., Rinaldi, R., & Maruccio, G. (2013). On-chip screening for prostate cancer: An EIS microfluidic platform for contemporary detection of free and total PSA. The Analyst, 138, 5404–5410. DOI: 10.1039/c3an00911d.

    Article  CAS  Google Scholar 

  • Cho, E. J., Lee, J. W., & Ellington, A. D. (2009). Applications of aptamers as sensors. Annual Review of Analytical Chemistry, 2, 241–264. DOI: 10.1146/annurev.anchem.1.031207.112851.

    Article  CAS  Google Scholar 

  • Chornokur, G., Arya, S. K., Phelan, C., Tanner, R., & Bhansali, S. (2011). Impedance-based miniaturized biosensor for ultrasensitive and fast prostate-specific antigen detection. Journal of Sensors, 2011, 983752. DOI: 10.1155/2011/983752.

    Article  CAS  Google Scholar 

  • Chou, E., & Simons, J. W. (1997). The molecular biology of prostate cancer morbidity and mortality: Accelerated death from ejaculate poisoning? Urologic Oncology: Seminars and Original Investigations, 3, 79–84. DOI: 10.1016/s1078-1439(97)00041-0.

    Article  CAS  Google Scholar 

  • Christensson, A. S., Björk, T., Nilsson, O., Dahlén, U., Matikainen, M.T., Cockett, A.T., Abrahamsson, P.A., & Lilja, H. (1993). Serum prostate specific antigen complexed to α-1-antichymotrypsin as an indicator of prostate cancer. Journal of Urology, 150, 100–105.

    CAS  Google Scholar 

  • Clark, S. L., & Remcho, V. T. (2002). Aptamers as analytical reagents. Electrophoresis, 23, 1335–1340. DOI: 10.1002/1522-2683(200205)23:9<1335::aid-elps1335>3.0.co;2-e.

    Article  CAS  Google Scholar 

  • D’Amico, A. V., Chen, M. H., Roehl, K. A., & Catalona, W. J. (2004). Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. New England Journal of Medicine, 351, 125–135. DOI: 10.1056/nejmoa032975.

    Article  Google Scholar 

  • D’Amico, A.V., Renshaw, A.A., Sussman, B., & Chen, M.H. (2005). Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. Journal ofthe American Medical Association, 294, 440–447. DOI: 10.1001/jama.294.4.440.

    Article  Google Scholar 

  • Feneley, M. R., Jan, H., Granowska, M., Mather, S. J., Ellison, D., Glass, J., Coptcoat, M., Kirby, R. S., Ogden, C., Oliver, R. T. D., Badenoch, D. F., Chinegwundoh, F. I., Nargund, V. H., Paris, A. M. I., & Britton, K. E. (2000). Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer. Prostate Cancer and Prostatic Diseases, 3, 47–52. DOI: 10.1038/sj.pcan.4500390.

    Article  CAS  Google Scholar 

  • Feng, K.J., Sun, C.H., Kang, Y., Chen, J.W., Jiang, J.H., Shen, G. L., & Yu, R. Q. (2008). Label-free electrochemical detection of nanomolar adenosine based on target-induced aptamer displacement. Electrochemistry Communications, 10, 531–535. DOI: 10.1016/j.elecom.2008.01.024.

    Article  CAS  Google Scholar 

  • Fernández-Sánchez, C., McNeil, C. J., Rawson, K., & Nilsson, O. (2004). Disposable noncompetitive immunosensor for free and total prostate-specific antigen based on capacitance measurement. Analytical Chemistry, 76, 5649–5656. DOI: 10.1021/ac0494937.

    Article  CAS  Google Scholar 

  • Formisano, N., Jolly, P., Cromhout, M., Fogel, R., Limson, J. L., & Estrela, P. (2014). Optimisation of an electrochemical impedance spectroscopy aptasensor by exploiting quartz crystal microbalance with dissipation signals. Sensors and Actuators B, submitted.

  • Ghosh, A., & Heston, W. D. W. (2004). Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. Journal of Cellular Biochemistry, 91, 528–539. DOI: 10.1002/jcb.10661.

    Article  CAS  Google Scholar 

  • Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000). Cancer statistics, 2000. CA: A Cancer Journal for Clinicians, 50, 7–33. DOI: 10.3322/canjclin.50.1.7.

    CAS  Google Scholar 

  • Grossklaus, D. J., Smith, J. A., Shappell, S. B., Coffey, C. S., Chang, S. S., & Cookson, M. S. (2002). The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA. Urologic Oncology: Seminars and Original Investigations, 7, 195–198. DOI: 10.1016/s1078-1439(02)00190-4.

    Article  CAS  Google Scholar 

  • Healy, D. A., Hayes, C. J., Leonard, P., McKenna, L., & O’Kennedy, R. (2007). Biosensor developments: Application to prostate-specific antigen detection. Trends in Biotechnology, 25, 125–131. DOI: 10.1016/j.tibtech.2007.01.004.

    Article  CAS  Google Scholar 

  • Hermann, T., & Patel, D. J. (2000). Adaptive recognition by nucleic acid aptamers. Science, 287, 820–825. DOI: 10.1126/science.287.5454.820.

    Article  CAS  Google Scholar 

  • Herne, T. M., & Tarlov, M. J. (1997). Characterization of DNA probes immobilized on gold surfaces. Journal of the American Chemical Society, 119, 8916–8920. DOI: 10.1021/ja9719586.

    Article  CAS  Google Scholar 

  • Hianik, T., & Wang, J. (2009). Electrochemical aptasensors — recent achievements and perspectives. Electroanalysis, 21, 1223–1235. DOI: 10.1002/elan.200904566.

    Article  CAS  Google Scholar 

  • Hoffman, R. M. (2011). Screening for prostate cancer. New England Journal ofMedicine, 365, 2013–2019. DOI: 10.1056/nejmcp1103642.

    Article  CAS  Google Scholar 

  • Huang, L., Reekmans, G., Saerens, D., Friedt, J. M., Frederix, F., Francis, L., Muyldermans, S., Campitelli, A., & Van Hoof, C. (2005). Prostate-specific antigen immunosensing based on mixed self-assembled monolayers, camel antibodies and colloidal gold enhanced sandwich assays. Biosensors and Bioelectronics, 21, 483–490. DOI: 10.1016/j.bios.2004.11.016.

    Article  CAS  Google Scholar 

  • Huang, Y. W., Wu, C. S., Chuang, C. K., Pang, S. T., Pan, T. M., Yang, Y. S., & Ko, F. H. (2013). Real-time and label-free detection of the prostate-specific antigen in human serum by a polycrystalline silicon nanowire field-effect transistor biosensor. Analytical Chemistry, 85, 7912–7918. DOI: 10.1021/ac401610s.

    Article  CAS  Google Scholar 

  • Ikebukuro, K., Kiyohara, C., & Sode, K. (2005). Novel electrochemical sensor system for protein using the aptamers in sandwich manner. Biosensors and Bioelectronics, 20, 2168–2172. DOI: 10.1016/j.bios.2004.09.002.

    Article  CAS  Google Scholar 

  • Iliuk, A. B., Hu, L. H., & Tao, W. A. (2011). Aptamer in bioanalytical applications. Analytical Chemistry, 83, 4440–4452. DOI: 10.1021/ac201057w.

    Article  CAS  Google Scholar 

  • Irani, J., Fournier, F., Bon, D., Gremmo, E., Dore, B., & Aubert, J. (1997). Patient tolerance of transrectal ultrasound-guided biopsy of the prostate. British Journal of Urology, 79, 608–610. DOI: 10.1046/j.1464-410x.1997.00120.x.

    Article  CAS  Google Scholar 

  • Jeong, S., Han, S. R., Lee, Y. J., & Lee, S. W. (2010). Selection of RNA aptamers specific to active prostate-specific antigen. Biotechnology Letters, 32, 379–385. DOI: 10.1007/s10529-009-0168-1.

    Article  CAS  Google Scholar 

  • Jiang, Z., Fanger, G. R., Woda, B. A., Banner, B. F., Algate, P., Dresser, K., Xu, J. C., & Chu, P. G. G. (2003). Expression of α-methylacyl-CoA racemase (p504s) in various malignant neoplasms and normal tissues: A study of 761 cases. Human Pathology, 34, 792–796. DOI: 10.1016/s0046-8177(03)00268-5.

    Article  CAS  Google Scholar 

  • Jolly, P., Formisano, N., Tkáč, J., Kasák, P., Frost, C. G., & Estrela, P. (2014). Label-free impedimetric prostate cancer aptasensor with antifouling surface chemistry. Analytical Chemistry, submitted.

  • Keighley, S. D., Li, P., Estrela, P., & Migliorato, P. (2008a). Optimization of DNA immobilization on gold electrodes for label-free detection by electrochemical impedance spectroscopy. Biosensors and Bioelectronics, 23, 1291–1297. DOI: 10.1016/j.bios.2007.11.012.

    Article  CAS  Google Scholar 

  • Keighley, S. D., Estrela, P., Li, P., & Migliorato, P. (2008b). Optimization of label-free DNA detection with electrochemical impedance spectroscopy using PNA probes. Biosensors and Bioelectronics, 24, 906–911. DOI: 10.1016/j.bios.2008.07.041.

    Article  CAS  Google Scholar 

  • Kirk, D. (1997). MRC study: When to commence treatment in advanced prostate cancer. Prostate Cancer and Prostatic Diseases, 1, 11–15.

    Article  CAS  Google Scholar 

  • Kufe, D. W., Pollock, R. E., Weichselbaum, R. R., Bast, R. C., Gansler, T. S., Holland, J. F., & Frei, E. (2003). Cancer medicine (6th ed.). Hamilton, ON, Canada: BC Decker.

    Google Scholar 

  • Lee, J. W., Sim, S. J., Cho, S. M., & Lee, J. (2005). Characterization of a self-assembled monolayer of thiol on a gold surface and the fabrication of a biosensor chip based on surface plasmon resonance for detecting anti-GAD antibody. Biosensors and Bioelectronics, 20, 1422–1427. DOI: 10.1016/j.bios.2004.04.017.

    Article  CAS  Google Scholar 

  • Li, C., Curreli, M., Lin, H., Lei, B., Ishikawa, F. N., Datar, R., Cote, R. J., Thompson, M. E., & Zhou, C. W. (2005). Complementary detection of prostate-specific antigen using In2O3 nanowires and carbon nanotubes. Journal of the American Chemical Society, 127, 12484–12485. DOI: 10.1021/ja053761g.

    Article  CAS  Google Scholar 

  • Lilja, H., Oldbring, J., Rannevik, G., & Laurell, C. B. (1987). Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. Journal of Clinical Investigation, 80, 281–285. DOI: 10.1172/jci113070.

    Article  CAS  Google Scholar 

  • Lilja, H., Ulmert, D., & Vickers, A. J. (2008). Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring. Nature Reviews Cancer, 8, 268–278. DOI: 10.1038/nrc2351.

    Article  CAS  Google Scholar 

  • Lim, Y. C., Kouzani, A. Z., & Duan, W. (2009). Aptasensors designconsiderations. In Z. H. Cai, Z. H. Li, Z. Kang, & Y. Liu (Eds.), Computational intelligence and intelligent systems (pp. 118–127). Berlin, Germany: Springer. DOI: 10.1007/978-3-642-04962-0_14.

    Chapter  Google Scholar 

  • Lin, J. H., & Ju, H. X. (2005). Electrochemical and chemiluminescent immunosensors for tumor markers. Biosensors and Bioelectronics, 20, 1461–1470. DOI: 10.1016/j.bios.2004.05.008.

    Article  CAS  Google Scholar 

  • Liu, B., Lu, L. S., Hua, E. H., Jiang, S. T., & Xie, G. M. (2012). Detection of the human prostate-specific antigen using an aptasensor with gold nanoparticles encapsulated by graphitized mesoporous carbon. Microchimica Acta, 178, 163–170. DOI: 10.1007/s00604-012-0822-5.

    Article  CAS  Google Scholar 

  • Liu, J., Lu, C. Y., Zhou, H., Xu, J. J., Wang, Z. H., & Chen, H. Y. (2013). A dual-functional electrochemical biosensor for the detection of prostate specific antigen and telomerase activity. Chemical Communications, 49, 6602–6604. DOI: 10.1039/c3cc43532f.

    Article  CAS  Google Scholar 

  • Loeb, S., & Catalona, W. J. (2007). Prostate-specific antigen in clinical practice. Cancer Letters, 249, 30–39. DOI: 10.1016/j.canlet.2006.12.022.

    Article  CAS  Google Scholar 

  • Loeb, S., Vellekoop, A., Ahmed, H. U., Catto, J., Emberton, M., Nam, R., Rosario, D. J., Scattoni, V., & Lotan, Y. (2013). Systematic review of complications of prostate biopsy. European Urology, 64, 876–892. DOI: 10.1016/j.eururo.2013.05.049.

    Article  Google Scholar 

  • Love, J. C., Estroff, L. A., Kriebel, J. K., Nuzzo, R. G., & Whitesides, G. M. (2005). Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chemical Reviews, 105, 1103–1170. DOI: 10.1021/cr0300789.

    Article  CAS  Google Scholar 

  • Lövgren, J., Valtonen-André, C., Marsal, K., Liua, H., & Lundwall, Å. (1999). Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids. Journal of Andrology, 20, 348–355. DOI: 10.1002/j.1939-4640.1999.tb02528.x.

    Google Scholar 

  • Lupold, S. E., Hicke, B. J., Lin, Y., & Coffey, D. S. (2002). Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Research, 62, 4029–4033.

    CAS  Google Scholar 

  • Madu, C. O., & Lu, Y. (2010). Novel diagnostic biomarkers for prostate cancer. Journal of Cancer, 1, 150–177. DOI: 10.7150/jca.1.150.

    Article  Google Scholar 

  • Mairal, T., Özalp, V. C., Sánchez, P. L., Mir, M., Katakis, I., & O’Sullivan, C. K. (2008). Aptamers: Molecular tools for analytical applications. Analytical and Bioanalytical Chemistry, 390, 989–1007. DOI: 10.1007/s00216-007-1346-4.

    Article  CAS  Google Scholar 

  • Mani, V., Chikkaveeraiah, B. V., Patel, V., Gutkind, J. S., & Rusling, J. F. (2009). Ultrasensitive immunosensor for cancer biomarker proteins using gold nanoparticle film electrodes and multienzyme-particle amplification. ACS Nano, 3, 585–594. DOI: 10.1021/nn800863w.

    Article  CAS  Google Scholar 

  • Melichar, B. (2012). Tumor biomarkers: PSA and beyond. Clinical Chemistry and Laboratory Medicine, 50, 1865–1869. DOI: 10.1515/cclm-2012-0631.

    CAS  Google Scholar 

  • Mikolajczyk, S. D., Marker, K. M., Millar, L. S., Kumar, A., Saedi, M.S., Payne, J.K., Evans, C.L., Gasoir, C.L., Linton, H. J., Carpenter, P., & Rittenhouse, H. G. (2001). A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer. Cancer Research, 61, 6958–6963.

    CAS  Google Scholar 

  • Mikolajczyk, S. D., Catalona, W. J., Evans, C. L., Linton, H. J., Millar, L. S., Marker, K. M., Katir, D., Amirkhan, A., & Rittenhouse, H. G. (2004). Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer. Clinical Chemistry, 50, 1017–1025. DOI: 10.1373/clinchem.2003.026823.

    Article  CAS  Google Scholar 

  • Min, K., Song, K.M., Cho, M., Chun, Y.S., Shim, Y.B., Ku, J. K., & Ban, C. (2010). Simultaneous electrochemical detection of both PSMA (+) and PSMA (−) prostate cancer cells using an RNA/peptide dual-aptamer probe. Chemical Communications, 46, 5566–5568. DOI: 10.1039/c002524k.

    Article  CAS  Google Scholar 

  • Moyer, V. A. (2012). Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 157, 120–134. DOI: 10.7326/0003-4819-157-2-201207170-00459.

    Article  Google Scholar 

  • Numnuam, A., Chumbimuni-Torres, K. Y., Xiang, Y., Bash, R., Thavarungkul, P., Kanatharana, P., Pretsch, E., Wang, J., & Bakker, E. (2008). Aptamer-based potentiometric measurements of proteins using ion-selective microelectrodes. Analytical Chemistry, 80, 707–712. DOI: 10.1021/ac701910r.

    Article  CAS  Google Scholar 

  • Ohori, M., Dunn, J. K., & Scardino, P. T. (1995). Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate-cancer? Urology, 46, 666–671. DOI: 10.1016/s0090-4295(99)80298-2.

    Article  CAS  Google Scholar 

  • Okuno, J., Maehashi, K., Kerman, K., Takamura, Y., Matsumoto, K., & Tamiya, E. (2007). Label-free immunosensor for prostate-specific antigen based on single-walled carbon nanotube array-modified microelectrodes. Biosensors and Bioelectronics, 22, 2377–2381. DOI: 10.1016/j.bios.2006.09.038.

    Article  CAS  Google Scholar 

  • Panini, N. V., Messina, G. A., Salinas, E., Fernández, H., & Raba, J. (2008). Integrated microfluidic systems with an immunosensor modified with carbon nanotubes for detection of prostate specific antigen (PSA) in human serum samples. Biosensors and Bioelectronics, 23, 1145–1151. DOI: 10.1016/j.bios.2007.11.003.

    Article  CAS  Google Scholar 

  • Pinsky, P. F., Andriole, G., Crawford, E. D., Chia, D., Kramer, B. S., Grubb, R., Greenlee, R., & Gohagan, J. K. (2007). Prostate-specific antigen velocity and prostate cancer gleason grade and stage. Cancer, 109, 1689–1695. DOI: 10.1002/cncr.22558.

    Article  Google Scholar 

  • Pircher, A., Hilbe, W., Heidegger, I., Drevs, J., Tichelli, A., & Medinger, M. (2011). Biomarkers in tumor angiogenesis and anti-angiogenic therapy. International Journal of Molecular Sciences, 12, 7077–7099. DOI: 10.3390/ijms12107077.

    Article  CAS  Google Scholar 

  • Putzbach, W., & Ronkainen, N. J. (2013). Immobilization techniques in the fabrication of nanomaterial-based electrochemical biosensors: A review. Sensors, 13, 4811–4840. DOI: 10.3390/s130404811.

    Article  CAS  Google Scholar 

  • Rodriguez, M. C., Kawde, A. N., & Wang, J. (2005). Aptamer biosensor for label-free impedance spectroscopy detection of proteins based on recognition-induced switching of the surface charge. Chemical Communications, 34, 4267–4269. DOI: 10.1039/b506571b.

    Article  CAS  Google Scholar 

  • Ross, R. K., Pike, M. C., Coetzee, G. A., Reichardt, J. K. V., Yu, M.C., Feigelson, H., Stanczyk, F.Z., Kolonel, L.N., & Henderson, B. E. (1998). Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Research, 58, 4497–4504.

    CAS  Google Scholar 

  • Rubin, M. A., Zhou, M., Dhanasekaran, S. M., Varambally, S., Barrette, T. R., Sanda, M. G., Pienta, K. J., Ghosh, D., & Chinnaiyan, A. M. (2002). α-Methylacyl coenzyme A race-mase as a tissue biomarker for prostate cancer. JAMA: Journal of the American Medical Association, 287, 1662–1670. DOI: 10.1001/jama.287.13.1662.

    Article  CAS  Google Scholar 

  • Sardesai, N. P., Barron, J. C., & Rusling, J. F. (2011). Carbon nanotube microwell array for sensitive electrochemiluminescent detection of cancer biomarker proteins. Analytical Chemistry, 83, 6698–6703. DOI: 10.1021/ac201292q.

    Article  CAS  Google Scholar 

  • Sarkar, P., Pal, P. S., Ghosh, D., Setford, S. J., & Tothill, I. E. (2002). Amperometric biosensors for detection of the prostate cancer marker (PSA). International Journal of Pharmaceutics, 238, 1–9. DOI: 10.1016/s0378-5173(02)00015-7.

    Article  CAS  Google Scholar 

  • Savory, N., Abe, K., Sode, K., & Ikebukuro, K. (2010). Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing. Biosensors and Bioelectronics, 26, 1386–1391. DOI: 10.1016/j.bios.2010.07.057.

    Article  CAS  Google Scholar 

  • Seto, Y., Iba, T., & Abe, K. (2001). Development of ultra-high sensitivity bioluminescent enzyme immunoassay for prostate-specific antigen (PSA) using firefly luciferase. Luminescence, 16, 285–290. DOI: 10.1002/bio.654.

    Article  CAS  Google Scholar 

  • Song, S. P., Wang, L. H., Li, J., Zhao, J. L., & Fan, C. H. (2008). Aptamer-based biosensors. TrAC Trends in Analytical Chemistry, 27, 108–117. DOI: 10.1016/j.trac.2007.12.004.

    Article  CAS  Google Scholar 

  • Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., & Redwine, E. (1987). Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New England Journal of Medicine, 317, 909–916. DOI: 10.1056/nejm198710083171501.

    Article  CAS  Google Scholar 

  • Stanford, J. L., Stephenson, R. A., Coyle, L. M., Cerhan, J., Correa, R., Eley, J. W., Gilliland, F., Hankey, B., Kolonel, L. N., Kosary, C., Ross, R., Severson, R., & West, D. (1999). Prostate cancer trends, 1973–1995. Bethesda, MD, USA: SEER Program, National Cancer Institute.

    Google Scholar 

  • Stephan, C., Lein, M., Jung, K., Schnorr, D., & Loening, S. A. (1997). The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia. Cancer, 79, 104–109. DOI: 10.1002/(sici)1097-0142(19970101)79:1<104::aid-cncr15>3.0.co;2-8.

    Article  CAS  Google Scholar 

  • Syed, M. A., & Pervaiz, S. (2010). Advances in aptamers. Oligonucleotides, 20, 215–224. DOI: 10.1089/oli.2010.0234.

    Article  CAS  Google Scholar 

  • Takayama, T. K., Fujikawa, K., & Davie, E. W. (1997). Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. Journal of Biological Chemistry, 272, 21582–21588. DOI: 10.1074/jbc.272.34.21582.

    Article  CAS  Google Scholar 

  • Tombelli, S., Minunni, M., & Mascini, M. (2005). Analytical applications of aptamers. Biosensors and Bioelectronics, 20, 2424–2434. DOI: 10.1016/j.bios.2004.11.006.

    Article  CAS  Google Scholar 

  • Uzzo, R. G., Wei, J. T., Waldbaum, R. S., Perlmutter, A. P., Byrne, J. C., & Vaughan, D., (1995). The influence of prostate size on cancer detection. Urology, 46, 831–836. DOI: 10.1016/s0090-4295(99)80353-7.

    Article  CAS  Google Scholar 

  • Velonas, V. M., Woo, H. H., dos Remedios, C. G., & Assinder, S. J. (2013). Current status of biomarkers for prostate cancer. International Journal of Molecular Sciences, 14, 11034–11060. DOI: 10.3390/ijms140611034.

    Article  CAS  Google Scholar 

  • Wang, X. Y., Zhou, J. M., Yun, W., Xiao, S. S., Chang, Z., He, P. G., & Fang, Y. Z. (2007). Detection of thrombin using electrogenerated chemiluminescence based on Ru(bpy)32+-doped silica nanoparticle aptasensor via target protein-induced strand displacement. Analytica Chimica Acta, 598, 242–248. DOI: 10.1016/j.aca.2007.07.050.

    Article  CAS  Google Scholar 

  • Wee, K. W., Kang, G. Y., Park, J., Kang, J. Y., Yoon, D. S., Park, J. H., & Kim, T. S. (2005). Novel electrical detection of label-free disease marker proteins using piezoresistive self-sensing micro-cantilevers. Biosensors and Bioelectronics, 20, 1932–1938. DOI: 10.1016/j.bios.2004.09.023.

    Article  CAS  Google Scholar 

  • Weeks, B. L., Camarero, J., Noy, A., Miller, A. E., De Yoreo, J. J., & Stanker, L. (2003). A microcantilever-based pathogen detector. Scanning, 25, 297–299. DOI: 10.1002/sca.4950250605.

    Article  CAS  Google Scholar 

  • Wu, C. L., Yang, X. J., Tretiakova, M., Patton, K. T., Halpern, E. F., Woda, B. A., Young, R. H., & Jiang, Z. (2004). Analysis of α-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Human Pathology, 35, 1008–1013. DOI: 10.1016/j.humpath.2004.03.019.

    Article  CAS  Google Scholar 

  • Willner, I., & Zayats, M. (2007). Electronic aptamer-based sensors. Angewandte Chemie International Edition, 46, 6408–6418. DOI: 10.1002/anie.200604524.

    Article  CAS  Google Scholar 

  • Xiao, Y., Lubin, A. A., Heeger, A. J., & Plaxco, K. W. (2005). Label-free electronic detection of thrombin in blood serum by using an aptamer-based sensor. Angewandte Chemie, 117, 5592–5595. DOI: 10.1002/ange.200500989.

    Article  Google Scholar 

  • Xu, D.K., Xu, D.W., Yu, X.B., Liu, Z.H., He, W., & Ma, Z.Q. (2005). Label-free electrochemical detection for aptamer-based array electrodes. Analytical Chemistry, 77, 5107–5113. DOI: 10.1021/ac050192m.

    Article  CAS  Google Scholar 

  • Yang, D. K., Chen, C. S., & Chen, L. C. (2013). Screening of functional aptamers against α-methylacyl-coA racemase. In Abstracts of the 13th American Institute of Chemical Engineers Annual Meeting, 3–8 November, 2013. San Francisco, CA, USA: American Institute of Chemical Engineers. Retrieved May 9, 2014, from https://aiche.confex.com/aiche/2013/webprogram/Paper332288.html

    Google Scholar 

  • Zani, A., Laschi, S., Mascini, M., & Marrazza, G. (2011). A new electrochemical multiplexed assay for PSA cancer marker detection. Electroanalysis, 23, 91–99. DOI: 10.1002/elan.201000486.

    Article  CAS  Google Scholar 

  • Zitzmann, S., Mier, W., Schad, A., Kinscherf, R., Askozylakis, V., Krämer, S., Altmann, A., Eisenhut, M., & Haberkorn, U. (2005). A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. Clinical Cancer Research, 11, 139–146.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Electronic & Electrical Engineering, University of Bath, Bath, BA2 7AY, UK

    Pawan Jolly, Nello Formisano & Pedro Estrela

Authors
  1. Pawan Jolly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nello Formisano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pedro Estrela
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pedro Estrela.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jolly, P., Formisano, N. & Estrela, P. DNA aptamer-based detection of prostate cancer. Chem. Pap. 69, 77–89 (2015). https://doi.org/10.1515/chempap-2015-0025

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1515/chempap-2015-0025

Keywords

Search

Navigation